These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 25467616)

  • 1. Microalbuminuria: a parameter that has changed diabetes care.
    Parving HH; Persson F; Rossing P
    Diabetes Res Clin Pract; 2015 Jan; 107(1):1-8. PubMed ID: 25467616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. YKL-40, a marker of inflammation and endothelial dysfunction, is elevated in patients with type 1 diabetes and increases with levels of albuminuria.
    Rathcke CN; Persson F; Tarnow L; Rossing P; Vestergaard H
    Diabetes Care; 2009 Feb; 32(2):323-8. PubMed ID: 18957531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between ABO blood groups and cardiovascular disease in type 1 diabetes according to diabetic nephropathy status.
    Parente EB; Harjutsalo V; Lehto M; Forsblom C; Sandholm N; Groop PH;
    Cardiovasc Diabetol; 2020 May; 19(1):68. PubMed ID: 32429911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preventing end-stage renal disease.
    Mogensen CE
    Diabet Med; 1998; 15 Suppl 4():S51-6. PubMed ID: 9868993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Is microalbuminuria, an early marker of clinical nephropathy, also a cardiovascular risk factor?].
    Raynaud E; Brun JF; Fédou C; Puech-Cathala AM; Pérez-Martin A; Orsetti A
    Ann Biol Clin (Paris); 1998; 56(6):671-9. PubMed ID: 9853026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microvascular disease: what does the UKPDS tell us about diabetic nephropathy?
    Bilous R
    Diabet Med; 2008 Aug; 25 Suppl 2():25-9. PubMed ID: 18717975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum amyloid A and C-reactive protein levels may predict microalbuminuria and macroalbuminuria in newly diagnosed type 1 diabetic patients.
    Overgaard AJ; McGuire JN; Hovind P; Parving HH; Rossing P; Pociot F
    J Diabetes Complications; 2013; 27(1):59-63. PubMed ID: 22885250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Twelve shifting paradigms in diabetic renal disease and hypertension.
    Mogensen CE
    Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S2-9. PubMed ID: 18947897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma high-sensitivity troponin T predicts end-stage renal disease and cardiovascular and all-cause mortality in patients with type 1 diabetes and diabetic nephropathy.
    Galsgaard J; Persson F; Hansen TW; Jorsal A; Tarnow L; Parving HH; Rossing P
    Kidney Int; 2017 Nov; 92(5):1242-1248. PubMed ID: 28712855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary tubular biomarkers as predictors of kidney function decline, cardiovascular events and mortality in microalbuminuric type 2 diabetic patients.
    Rotbain Curovic V; Hansen TW; Eickhoff MK; von Scholten BJ; Reinhard H; Jacobsen PK; Persson F; Parving HH; Rossing P
    Acta Diabetol; 2018 Nov; 55(11):1143-1150. PubMed ID: 30105469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetic nephropathy: diagnosis, prevention, and treatment.
    Gross JL; de Azevedo MJ; Silveiro SP; Canani LH; Caramori ML; Zelmanovitz T
    Diabetes Care; 2005 Jan; 28(1):164-76. PubMed ID: 15616252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The link between microalbuminuria, endothelial dysfunction and cardiovascular disease in diabetes.
    Naidoo DP
    Cardiovasc J S Afr; 2002; 13(4):194-9. PubMed ID: 12389063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognosis and treatment of diabetic nephropathy: Recent advances and perspectives.
    Rossing P; Persson F; Frimodt-Møller M
    Nephrol Ther; 2018 Apr; 14 Suppl 1():S31-S37. PubMed ID: 29606261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of early nephropathy in diabetic patients.
    Mogensen CE
    Annu Rev Med; 1995; 46():79-93. PubMed ID: 7598486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [How I evaluate...diabetic nephropathy. First part: micro- and macroalbuminuria].
    Weekers L; Scheen AJ; Lefebvre PJ
    Rev Med Liege; 1998 Aug; 53(8):494-8. PubMed ID: 9810212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease?
    Chico A; Pérez A; Córdoba A; Arcelús R; Carreras G; de Leiva A; González-Sastre F; Blanco-Vaca F
    Diabetologia; 1998 Jun; 41(6):684-93. PubMed ID: 9662051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microalbuminuria: a marker to increased renal and cardiovascular risk in diabetes mellitus.
    McKenna K; Thompson C
    Scott Med J; 1997 Aug; 42(4):99-104. PubMed ID: 9507584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remission to normoalbuminuria during multifactorial treatment preserves kidney function in patients with type 2 diabetes and microalbuminuria.
    Gaede P; Tarnow L; Vedel P; Parving HH; Pedersen O
    Nephrol Dial Transplant; 2004 Nov; 19(11):2784-8. PubMed ID: 15328385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Albuminuria: a target for treatment of type 2 diabetic nephropathy.
    de Zeeuw D
    Semin Nephrol; 2007 Mar; 27(2):172-81. PubMed ID: 17418686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary albumin excretion rate and its determinants after 6 years in non-insulin-dependent diabetic patients.
    Wirta OR; Pasternack AI; Mustonen JT; Koivula TA; Harmoinen A
    Nephrol Dial Transplant; 1996 Mar; 11(3):449-56. PubMed ID: 8671814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.